Key Insights

Highlights

Success Rate

73% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 49/100

Termination Rate

11.5%

3 terminated out of 26 trials

Success Rate

72.7%

-13.8% vs benchmark

Late-Stage Pipeline

19%

5 trials in Phase 3/4

Results Transparency

50%

4 of 8 completed with results

Key Signals

4 with results73% success

Data Visualizations

Phase Distribution

18Total
Not Applicable (12)
P 2 (1)
P 3 (3)
P 4 (2)

Trial Status

Completed8
Unknown8
Terminated3
Recruiting2
Withdrawn2
Not Yet Recruiting2

Trial Success Rate

72.7%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (26)

Showing 20 of 20 trials
NCT07473284Not Yet Recruiting

Incidence and Characteristic of CRT Persistent After Catheter Extraction in ICU Patients

NCT03250247Not ApplicableActive Not Recruiting

Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy (The C-TRACT Trial)

NCT04319627Phase 3Recruiting

Statins for Venous Event Reduction in Patients With Venous Thromboembolism

NCT05622500Not ApplicableTerminated

Best Endovenous Treatment, Including STenting, Versus Non-endovenous Treatment in Chronic Proximal Deep Venous Disease

NCT05794932Not ApplicableCompletedPrimary

Exercise Tolerance After Venous Recanalization for Post-thrombotic Syndrome

NCT06925698Phase 3Not Yet Recruiting

Immunosuppressive Therapy Alone Versus Plus Oral Anticoagulation in the Treatment of VT Associated With Behcet's Disease

NCT04794569Phase 4Terminated

Tinzaparin Lead-In to Prevent the Post-Thrombotic Syndrome

NCT04103112Not ApplicableTerminated

Compression Hosiery to Avoid Post-Thrombotic Syndrome

NCT04825548Completed

Post-thrombotic Syndrome After Deep Venous Thrombosis (DVT) in Patients Treated According to the NOPHO ALL2008 Protocol

NCT04250025Not ApplicableUnknownPrimary

Angioplasty-stenting vs Optimal Medical Treatment on Post-thrombotic Syndrome Reduction

NCT03757481Not ApplicableCompletedPrimary

Long-term Outcome After Heparin and Edoxaban Versus Heparin Plus Vit K Antagonists for Acute DVT and PE

NCT06046807UnknownPrimary

Long-Term Post Thrombotic Syndrome Assessment (CELEST Long Term).

NCT05744843Not ApplicableRecruitingPrimary

Structured Exercise Versus Endovascular Reconstruction in Post Thrombotic Syndrome

NCT03054727CompletedPrimary

Long Term Assessment of Post Thrombotic Syndrome : OPTIMEV Study ( SPOT )

NCT03368313Not ApplicableUnknown

Non-elastic Compression Garment Therapy Versus Control for Deep Vein Thrombosis

NCT05296499Unknown

EXERT: Exercise Physiology After Thrombosis

NCT04411316Phase 4Withdrawn

Catheter-directed Thrombolysis Compared to Anticoagulation Alone for Acute Primary Iliofemoral Deep Venous Thrombosis

NCT03075761Not ApplicableCompletedPrimary

Physical Activity in Children at Risk of Post-thrombotic Sequelae (PACT)

NCT00633971Not ApplicableCompletedPrimary

Treatment Trial for Post-Thrombotic Syndrome

NCT04007653Unknown

Long-term Outcome After Edoxaban Versus Vitamin K Antagonists for Acute VTE

Scroll to load more

Research Network

Activity Timeline